相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Randomized Controlled Trial on Efficacy of Surgical Excision of Nondysplastic Leukoplakia to Prevent Oral Cancer
Paolo G. Arduino et al.
CANCER PREVENTION RESEARCH (2021)
Molecular, genomic and mutational landscape of oral leukoplakia
Camile S. Farah
ORAL DISEASES (2021)
Targeting of CD40 and PD-L1 Pathways Inhibits Progression of Oral Premalignant Lesions in a Carcinogen-induced Model of Oral Squamous Cell Carcinoma
Jose A. Monteiro de Oliveira Novaes et al.
CANCER PREVENTION RESEARCH (2021)
Dysplasia and DNA ploidy to prognosticate clinical outcome in oral potentially malignant disorders
Hans Prakash Sathasivam et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2021)
The potential role of Photodynamic therapy in oral premalignant and malignant lesions: A systematic review
Antonio Romano et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2021)
SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia-a phase II randomised control trial study protocol
Caroline McCarthy et al.
TRIALS (2021)
Window of opportunity clinical trial designs to study cancer metabolism
Francesca Aroldi et al.
BRITISH JOURNAL OF CANCER (2020)
Effective delivery of Complex Innovative Design (CID) cancer trials-A consensus statement
Sarah P. Blagden et al.
BRITISH JOURNAL OF CANCER (2020)
Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics
Alan Talevi et al.
EXPERT OPINION ON DRUG DISCOVERY (2020)
Potentially malignant disorders of the oral cavity and oral dysplasia: A systematic review and meta-analysis of malignant transformation rate by subtype
Oreste Iocca et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2020)
Methods for safety and endpoint ascertainment: identification of adverse events through scrutiny of negatively adjudicated events
Alexander C. Fanaroff et al.
TRIALS (2020)
Intra-observer and inter-observer variability in two grading systems for oral epithelial dysplasia: A multi-centre study in India
Kannan Ranganathan et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2020)
HNSCC: Tumour Antigens and Their Targeting by Immunotherapy
Adrian von Witzleben et al.
CELLS (2020)
Genetic Susceptibility in Head and Neck Squamous Cell Carcinoma in a Spanish Population
Javier Fernandez-Mateos et al.
CANCERS (2019)
Analysis of head and neck carcinoma progression reveals novel and relevant stage-specific changes associated with immortalisation and malignancy
Ratna Veeramachaneni et al.
SCIENTIFIC REPORTS (2019)
How to design a dose-finding study using the continual reassessment method
Graham M. Wheeler et al.
BMC MEDICAL RESEARCH METHODOLOGY (2019)
Practical risk management in early phase clinical trials
Simon Coates et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
Yuan Cheng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
Met Receptor Tyrosine Kinase and Chemoprevention of Oral Cancer
Pierre Saintigny et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Met Receptor Tyrosine Kinase and Chemoprevention of Oral Cancer
Pierre Saintigny et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Characterization of epithelial oral dysplasia in non-smokers: First steps towards precision medicine
L. D. Rock et al.
ORAL ONCOLOGY (2018)
Protective effects of metformin, statins and anti-inflammatory drugs on head and neck cancer: A systematic review
Constanza Saka Herran et al.
ORAL ONCOLOGY (2018)
Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy
Rogerio M. Castilho et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Composite End Points in Clinical Research A Time for Reappraisal
Paul W. Armstrong et al.
CIRCULATION (2017)
Update from the 4th Edition of the World Health Organization of Head and Neck Tumours: Tumours of the Oral Cavity and Mobile Tongue
Susan Mueller
HEAD & NECK PATHOLOGY (2017)
TP53 Mutations in Head and Neck Squamous Cell Carcinoma and Their Impact on Disease Progression and Treatment Response
Ge Zhou et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2016)
Leveraging premalignant biology for immune-based cancer prevention
Avrum Spira et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Pharmacodynamic endpoints as clinical trial objectives to answer important questions in oncology drug development
Ralph E. Parchment et al.
SEMINARS IN ONCOLOGY (2016)
Erlotinib and the Risk of Oral Cancer The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial
William N. William et al.
JAMA ONCOLOGY (2016)
Progress in Immunotherapy of Head and Neck Squamous Cell Carcinoma
Salah Almokadem
CURRENT MOLECULAR PHARMACOLOGY (2016)
Interventions for treating oral leukoplakia to prevent oral cancer
Giovanni Lodi et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2016)
Comprehensive genomic characterization of head and neck squamous cell carcinomas
Michael S. Lawrence et al.
NATURE (2015)
The management of oral epithelial dysplasia: The Liverpool algorithm
E. A. Field et al.
ORAL ONCOLOGY (2015)
Pharmacologic Therapy of Diabetes and Overall Cancer Risk and Mortality: A Meta-Analysis of 265 Studies
Lang Wu et al.
SCIENTIFIC REPORTS (2015)
Treatment of oral leukoplakia with a low-dose of beta-carotene and vitamin C supplements: A randomized controlled trial
Toru Nagao et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Long-term use of valproic acid in US veterans is associated with a reduced risk of smoking-related cases of head and neck cancer
Hyunseok Kang et al.
CANCER (2014)
Delineating an epigenetic continuum in head and neck cancer
Maria J. Worsham et al.
CANCER LETTERS (2014)
Chemoprevention of Head and Neck Cancer with Celecoxib and Erlotinib: Results of a Phase Ib and Pharmacokinetic
Nabil F. Saba et al.
CANCER PREVENTION RESEARCH (2014)
Topical Application of a Mucoadhesive Freeze-Dried Black Raspberry Gel Induces Clinical and Histologic Regression and Reduces Loss of Heterozygosity Events in Premalignant Oral Intraepithelial Lesions: Results from a Multicentered, Placebo-Controlled Clinical Trial
Susan R. Mallery et al.
CLINICAL CANCER RESEARCH (2014)
Phase 1 Trial Design: Is 3+3 the Best?
Aaron R. Hansen et al.
CANCER CONTROL (2014)
Outcomes of oral squamous cell carcinoma arising from oral epithelial dysplasia: rationale for monitoring premalignant oral lesions in a multidisciplinary clinic
M. W. Ho et al.
BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY (2013)
Optimizing Biomarkers and Endpoints in Oral Cancer Chemoprevention Trials
William N. William et al.
CANCER PREVENTION RESEARCH (2013)
Bowman Birk Inhibitor Concentrate and Oral Leukoplakia: A Randomized Phase IIb Trial
William B. Armstrong et al.
CANCER PREVENTION RESEARCH (2013)
Chemoprevention of Head and Neck Cancer by Simultaneous Blocking of Epidermal Growth Factor Receptor and Cyclooxygenase-2 Signaling Pathways: Preclinical and Clinical Studies
Dong M. Shin et al.
CLINICAL CANCER RESEARCH (2013)
Photodynamic therapy: a review and its prospective role in the management of oral potentially malignant disorders
R. Saini et al.
ORAL DISEASES (2013)
A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia
Stuart J. Wong et al.
ORAL ONCOLOGY (2013)
Loss of Heterozygosity (LOH) Profiles-Validated Risk Predictors for Progression to Oral Cancer
Lewei Zhang et al.
CANCER PREVENTION RESEARCH (2012)
Recurrence patterns of oral leukoplakia after curative surgical resection: important factors that predict the risk of recurrence and malignancy
Yuri Kuribayashi et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2012)
CO2 laser of oral dysplasia: clinicopathological features of recurrence and malignant transformation
Waseem Jerjes et al.
LASERS IN MEDICAL SCIENCE (2012)
The clinical determinants of malignant transformation in oral epithelial dysplasia
M. W. Ho et al.
ORAL ONCOLOGY (2012)
Gene Expression Profiling Predicts the Development of Oral Cancer
Pierre Saintigny et al.
CANCER PREVENTION RESEARCH (2011)
Malignant transformation of oral epithelial dysplasia: clinicopathological risk factors and outcome analysis in a retrospective cohort of 138 cases
Wei Liu et al.
HISTOPATHOLOGY (2011)
Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal-Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)
J. Jean Cui et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
Peter M. Rothwell et al.
LANCET (2011)
Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1
Nishant Agrawal et al.
SCIENCE (2011)
The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
Nicolas Stransky et al.
SCIENCE (2011)
Topical photodynamic therapy is very effective for oral verrucous hyperplasia and oral erythroleukoplakia
Hung-Pin Lin et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2010)
Chemoprevention of oral cancer in animal models, and effect on leukoplakias in human patients with ZengShengPing, a mixture of medicinal herbs
Zheng Sun et al.
ORAL ONCOLOGY (2010)
Oral epithelial dysplasia in non-users of tobacco and alcohol: an analysis of clinicopathologic characteristics and treatment outcome
Mohamed A. Jaber
Journal of Oral Science (2010)
Phase II Randomized, Placebo-Controlled Trial of Green Tea Extract in Patients with High-Risk Oral Premalignant Lesions
Anne S. Tsao et al.
CANCER PREVENTION RESEARCH (2009)
High-Dose Fenretinide in Oral Leukoplakia
William N. William et al.
CANCER PREVENTION RESEARCH (2009)
TREATMENT AND FOLLOW-UP OF ORAL DYSPLASIA - A SYSTEMATIC REVIEW AND META-ANALYSIS
Hisham M. Mehanna et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2009)
Comparison of Clinical Outcomes of Oral Erythroleukoplakia Treated with Photodynamic Therapy Using Either Light-Emitting Diode or Laser Light
Chuan-Hang Yu et al.
LASERS IN SURGERY AND MEDICINE (2009)
Oral cancer prevention and control - The approach of the World Health Organization
Poul Erik Petersen
ORAL ONCOLOGY (2009)
A Pilot Surrogate Endpoint Biomarker Study of Celecoxib in Oral Premalignant Lesions
Lori J. Wirth et al.
CANCER PREVENTION RESEARCH (2008)
Pilot randomized phase II study of celecoxib in oral premalignant lesions
Vassiliki A. Papaclimitrakopoulou et al.
CLINICAL CANCER RESEARCH (2008)
Molecular genetics of premalignant oral lesions
S. K. Mithani et al.
ORAL DISEASES (2007)
Long-term treatment outcome of oral premalignant lesions
P. Holmstrup et al.
ORAL ONCOLOGY (2006)
Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer
MF Fraga et al.
NATURE GENETICS (2005)
The results of CO2 laser surgery in patients with oral leukoplakia: a 25 year follow
PS van der Hem et al.
ORAL ONCOLOGY (2005)
Efficacy of oral lycopene in the treatment of oral leukoplakia
M Singh et al.
ORAL ONCOLOGY (2004)
Laser surgery as a treatment for oral leukoplakia
J Ishii et al.
ORAL ONCOLOGY (2003)
Meta-tetra(hydroxyphenyl)chlorin photodynamic therapy in early-stage squamous cell carcinoma of the head and neck
MP Copper et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2003)
Role of areca nut in betel quid-associated chemical carcinogenesis: current awareness and future perspectives
JH Jeng et al.
ORAL ONCOLOGY (2001)
分享论文
